According to Amedisys's latest financial reports the company's current revenue (TTM) is $2.25 B. In 2022 the company made a revenue of $2.22 B an increase over the years 2021 revenue that were of $2.21 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $2.23 B | 0.59% |
2022 | $2.22 B | 0.41% |
2021 | $2.21 B | 6.88% |
2020 | $2.07 B | 5.93% |
2019 | $1.95 B | 17.63% |
2018 | $1.66 B | 9.56% |
2017 | $1.51 B | 5.57% |
2016 | $1.43 B | 12.25% |
2015 | $1.28 B | 6.31% |
2014 | $1.20 B | -3.48% |
2013 | $1.24 B | -14.59% |
2012 | $1.46 B | 0.39% |
2011 | $1.45 B | -10.94% |
2010 | $1.63 B | 7.99% |
2009 | $1.51 B | 27.46% |
2008 | $1.18 B | 70.13% |
2007 | $0.69 B | 28.97% |
2006 | $0.54 B | 41.83% |
2005 | $0.38 B | 68.02% |
2004 | $0.22 B | 59.39% |
2003 | $0.14 B | 10.08% |
2002 | $0.12 B | 13.36% |
2001 | $0.11 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
LHC Group LHCG | $2.28 B | 1.39% | ๐บ๐ธ USA |
National Healthcare
NHC | $1.14 B | -49.30% | ๐บ๐ธ USA |
Chemed CHE | $2.29 B | 1.87% | ๐บ๐ธ USA |